Cargando…
MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
BACKGROUND: About 70% of all breast cancers are estrogen receptor alpha positive (ER+) and are treated with antiestrogens. However, 50% of ER + tumors develop resistance to these drugs (endocrine resistance). In endocrine resistant cells, an adaptive pathway called the unfolded protein response (UPR...
Autores principales: | Shajahan-Haq, Ayesha N, Cook, Katherine L, Schwartz-Roberts, Jessica L, Eltayeb, Ahreej E, Demas, Diane M, Warri, Anni M, Facey, Caroline O B, Hilakivi-Clarke, Leena A, Clarke, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216870/ https://www.ncbi.nlm.nih.gov/pubmed/25339305 http://dx.doi.org/10.1186/1476-4598-13-239 |
Ejemplares similares
-
Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014) -
Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
por: de Assis, Sonia, et al.
Publicado: (2010) -
Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer
por: Demas, Diane M., et al.
Publicado: (2019) -
Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021) -
Mathematical modelling of breast cancer cells in response to endocrine therapy and Cdk4/6 inhibition
por: He, Wei, et al.
Publicado: (2020)